Related Experiment Videos
Hematological Effects of Human Immunodeficiency Virus Infection
1Division of Medical Oncology and Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida 33612, USA.
Cancer Control : Journal of the Moffitt Cancer Center
|March 1, 1995
Summary
Hematologic abnormalities like anemia and thrombocytopenia are common in human immunodeficiency virus (HIV) infection, worsening with disease progression to acquired immunodeficiency syndrome (AIDS). These conditions stem from various factors including viral effects, infections, and treatment side effects.
Area of Science:
- Hematology
- Infectious Diseases
- Immunology
Background:
- Hematologic abnormalities, including anemia, thrombocytopenia, and neutropenia, are frequently observed in patients with human immunodeficiency virus (HIV) infection.
- These conditions tend to increase in frequency and severity as HIV infection progresses from an asymptomatic state to acquired immunodeficiency syndrome (AIDS).
Purpose of the Study:
- To elucidate the diverse causes and mechanisms underlying hematologic manifestations in HIV/AIDS patients.
- To provide a comprehensive overview of the hematological complications associated with HIV infection.
Main Methods:
- Review of existing literature on hematologic abnormalities in HIV/AIDS.
- Analysis of the etiological factors contributing to anemia, thrombocytopenia, neutropenia, and lymphopenia in the context of HIV infection.
Main Results:
- Anemia in AIDS can result from nutritional deficiencies, infections, antiretroviral drug toxicity, direct viral effects on bone marrow, autoimmune hemolysis, and gastrointestinal blood loss.
- Neutropenia may arise from infection, autoimmunity, or bone marrow suppression by drugs or HIV. Lymphopenia, particularly affecting T-helper cells, is a direct cytopathic effect of the virus.
- Thrombocytopenia can be caused by autoantibodies (idiopathic thrombocytopenic purpura-like state), bone marrow suppression, thrombotic thrombocytopenic purpura, or coagulopathies like lupus anticoagulant.
Conclusions:
- Hematologic abnormalities are integral to the clinical spectrum of HIV/AIDS, driven by a complex interplay of viral pathogenesis, opportunistic infections, and iatrogenic factors.
- Understanding these mechanisms is crucial for effective management and monitoring of patients with HIV/AIDS.